165 related articles for article (PubMed ID: 9331631)
1. Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation.
Holm SE; Köhler W; Kaplan EL; Schlievert PM; Alouf JE; Stevens DL; Kotb M
Adv Exp Med Biol; 1997; 418():193-9. PubMed ID: 9331631
[No Abstract] [Full Text] [Related]
2. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
Norrby-Teglund A; Low DE; McGeer A; Kotb M
Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
[No Abstract] [Full Text] [Related]
3. Cytokine profile of human peripheral blood mononucleated cells stimulated with a novel streptococcal superantigen, SPEA, SPEC and group A streptococcal cells.
Müller-Alouf H; Capron M; Alouf JE; Geoffroy C; Gerlach D; Ozegowski JH; Fitting C; Cavaillon JM
Adv Exp Med Biol; 1997; 418():929-31. PubMed ID: 9331802
[No Abstract] [Full Text] [Related]
4. [Superantigens and toxic shock syndrome. A report of three cases treated with intravenous gammaglobulin].
Vázquez García RE; Hernández Bautista V; Espinosa Padilla S
Rev Alerg Mex; 2006; 53(5):183-8. PubMed ID: 17357565
[TBL] [Abstract][Full Text] [Related]
5. Superantigens and streptococcal toxic shock syndrome.
Proft T; Sriskandan S; Yang L; Fraser JD
Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
[TBL] [Abstract][Full Text] [Related]
6. Changing group A streptococci. The reappearance of streptococcal 'toxic shock'.
Stollerman GH
Arch Intern Med; 1988 Jun; 148(6):1268-70. PubMed ID: 3288156
[No Abstract] [Full Text] [Related]
7. Streptococcal toxic shock syndrome.
Köhler W
Zentralbl Bakteriol; 1990 Mar; 272(3):257-64. PubMed ID: 2184817
[No Abstract] [Full Text] [Related]
8. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
[TBL] [Abstract][Full Text] [Related]
9. 'Toxic strep syndrome'. A manifestation of group A streptococcal infection.
Bartter T; Dascal A; Carroll K; Curley FJ
Arch Intern Med; 1988 Jun; 148(6):1421-4. PubMed ID: 3288161
[TBL] [Abstract][Full Text] [Related]
10. [Surprises of streptococcal infection].
Beliakov VD
Vestn Ross Akad Med Nauk; 1996; (11):24-8. PubMed ID: 9011276
[No Abstract] [Full Text] [Related]
11. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome.
Stevens DL
Clin Infect Dis; 1998 Mar; 26(3):639-41. PubMed ID: 9524836
[No Abstract] [Full Text] [Related]
12. Streptococcal toxic shock-like syndrome as a complication of varicella.
Bradley JS; Schlievert PM; Sample TG
Pediatr Infect Dis J; 1991 Jan; 10(1):77-9. PubMed ID: 2003062
[No Abstract] [Full Text] [Related]
13. [Case of severe streptococcus pyogenes pneumonia with streptococcus toxic shock syndrome].
Izumiyama N; Miki H; Shishikura Y; Kawaguchi C; Saitou W; Kikuchi T; Kumagai K; Sasamori K; Kikuchi Y
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):488-92. PubMed ID: 18592996
[TBL] [Abstract][Full Text] [Related]
14. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin therapy for toxic shock syndrome.
Barry W; Hudgins L; Donta ST; Pesanti EL
JAMA; 1992 Jun; 267(24):3315-6. PubMed ID: 1597914
[TBL] [Abstract][Full Text] [Related]
16. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics.
Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S
J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377
[TBL] [Abstract][Full Text] [Related]
17. T cell activation and cytokine release in streptococcal toxic shock-like syndrome.
Nadal D; Lauener RP; Braegger CP; Kaufhold A; Simma B; Lütticken R; Seger RA
J Pediatr; 1993 May; 122(5 Pt 1):727-9. PubMed ID: 8496751
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.
Perez CM; Kubak BM; Cryer HG; Salehmugodam S; Vespa P; Farmer D
Am J Med; 1997 Jan; 102(1):111-3. PubMed ID: 9209207
[No Abstract] [Full Text] [Related]
19. Invasive group A streptococcal disease. Association with a lack of anti-exotoxin antibodies.
Mascini EM; Hazenberg MM; van Dalen A; Verhoef-Verhage LA; van Leeuwen NJ; Verhoef J; van Dijk H
Adv Exp Med Biol; 1997; 418():921-2. PubMed ID: 9331799
[No Abstract] [Full Text] [Related]
20. Streptococcal puerperal sepsis and obstetric infections: a historical perspective.
Charles D; Larsen B
Rev Infect Dis; 1986; 8(3):411-22. PubMed ID: 3523698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
